Raleigh pharma raising $122M to prep for potential commercialization

A Raleigh company developing a COPD treatment is raising more than $100 million as it moves closer to seeking regulatory approval.

Source: bizjournals.com Health Care:Physician Practices headlines - August 14, 2022 Category: American Health Authors: Zac Ezzone Source Type: news